The U.S. Navy commissioned David Schmidt, owner of Advanced Applications Group, to create a device for sailors to enhance their physical capabilities. The resulting product, developed in collaboration with the military, became the foundation for LifeWave, a company offering wearable light technology. One of its flagship products, the X39 patch, is marketed as a tool to stimulate stem cell production and reverse aging symptoms.
The X39 patch, worn on the neck, claims to activate GHK-cu, a copper peptide that signals the body to generate new stem cells. Proponents suggest it addresses age-related issues such as joint pain, wrinkles, and fatigue. Testimonials describe rapid relief from lower back pain, chest discomfort, and knee inflammation after use. The patch is also promoted as an alternative to costly medical procedures like stem cell injections, which can exceed $50,000 per treatment.
LifeWave offers additional patches, including the Aeon (targeting inflammation) and IceWave (for pain relief). Users report enhanced physical performance and recovery when combining products. The technology is described as a breakthrough in self-care, bypassing traditional medical systems.
The article emphasizes personal experiences, such as one user’s elimination of chronic back pain within days, and highlights the product’s potential to “reverse aging” through cellular regeneration. It concludes with encouragement to explore the patches as a health solution, while noting skepticism from mainstream medical institutions.